Literature DB >> 3433001

Urinary excretion of hyaluronan in man.

T C Laurent1, K Lilja, L Brunnberg, A Engström-Laurent, U B Laurent, U Lindqvist, K Murata, D Ytterberg.   

Abstract

A specific assay for hyaluronan (hyaluronic acid) has been applied to the determination of the polysaccharide in urine. The excretion in 22 healthy subjects was 330 micrograms/24 h (SD 77). The excretion was correlated with body weight and was therefore somewhat higher in males than in females. The molecular weight of the main fraction of urinary hyaluronan was in the range of 4000 to 12,000 in accordance with the hypothesis that it originates from blood and arises by glomerular filtration. A small fraction was of higher molecular weight and could have been produced in the urinary tract. Hyaluronan in male and female urine displayed the same molecular weight distributions. Patients with rheumatoid arthritis and primary biliary cirrhosis showed a two-fold and three-fold increase, respectively, of hyaluronan in urine with concurrently high levels of the polysaccharide in serum. A patient with Werner's syndrome displayed a ten-fold increase of the polysaccharide in both serum and urine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3433001

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  11 in total

1.  Hyaluronan is not elevated in urine or serum in Hutchinson-Gilford Progeria Syndrome.

Authors:  Leslie B Gordon; Ingrid A Harten; Anthony Calabro; Geetha Sugumaran; Antonei B Csoka; W Ted Brown; Vincent Hascall; Bryan P Toole
Journal:  Hum Genet       Date:  2003-05-01       Impact factor: 4.132

Review 2.  Scavenger functions of the liver endothelial cell.

Authors:  B Smedsrød; H Pertoft; S Gustafson; T C Laurent
Journal:  Biochem J       Date:  1990-03-01       Impact factor: 3.857

3.  Circulating hyaluronan, chondroitin sulphate and dextran sulphate bind to a liver receptor that does not recognize heparin.

Authors:  S Gustafson; T Björkman
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

Review 4.  Hyaluronan as an immune regulator in human diseases.

Authors:  Dianhua Jiang; Jiurong Liang; Paul W Noble
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

5.  Elimination of stabilised hyaluronan from the knee joint in healthy men.

Authors:  Ulla Lindqvist; Vladimir Tolmachev; Kalevi Kairemo; Gunnar Aström; Eva Jonsson; Hans Lundqvist
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 6.  Biology of hyaluronan: Insights from genetic disorders of hyaluronan metabolism.

Authors:  Barbara Triggs-Raine; Marvin R Natowicz
Journal:  World J Biol Chem       Date:  2015-08-26

Review 7.  Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing.

Authors:  K L Goa; P Benfield
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

Review 8.  HYAL-2-WWOX-SMAD4 Signaling in Cell Death and Anticancer Response.

Authors:  Li-Jin Hsu; Ming-Fu Chiang; Chun-I Sze; Wan-Pei Su; Ye Vone Yap; I-Ting Lee; Hsiang-Ling Kuo; Nan-Shan Chang
Journal:  Front Cell Dev Biol       Date:  2016-12-06

Review 9.  A Trickster in Disguise: Hyaluronan's Ambivalent Roles in the Matrix.

Authors:  Lena Bohaumilitzky; Ann-Kathrin Huber; Eva Maria Stork; Simon Wengert; Franziska Woelfl; Heike Boehm
Journal:  Front Oncol       Date:  2017-10-09       Impact factor: 6.244

10.  Endothelial glycocalyx damage in kidney disease correlates with uraemic toxins and endothelial dysfunction.

Authors:  Hui Liew; Matthew A Roberts; Alun Pope; Lawrence P McMahon
Journal:  BMC Nephrol       Date:  2021-01-10       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.